Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Chromatography. A|February 26, 2008
Quantitative analysis of metabolites in complex biological samples using ion-pair reversed-phase liquid chromatography-isotope dilution tandem mass spectrometryReza M Seifar, Zheng Zhao, Jan van Dam, et al.
Trials|January 28, 2023
Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL studyCornelis Jan van Dam, Monique van Velzen, Cornelis Kramers, et al.
Microbial Cell Factories|June 19, 2012
Quantitative metabolomics analysis of amino acid metabolism in recombinant Pichia pastoris under different oxygen availability conditionsMarc Carnicer, Angela Ten Pierick, Jan van Dam, et al.
Obstetrics and Gynecology International|September 24, 2011
Are costs of robot-assisted surgery warranted for gynecological procedures?Peter van Dam, Jan Hauspy, Luc Verkinderen, et al.
Anesthesiology|August 14, 2020
Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus MorphineAlbert Dahan, C Jan van Dam, Marieke Niesters, et al.
Annals of Palliative Medicine|December 24, 2019
Opioid utility function: methods and implicationsCornelis Jan van Dam, Marijke Hyke Algera, Erik Olofsen, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 27, 2012
Development of quantitative metabolomics for Pichia pastorisMarc Carnicer, André B Canelas, Angela Ten Pierick, et al.
International Journal for Parasitology|May 15, 2012
Proliferating bloodstream-form Trypanosoma brucei use a negligible part of consumed glucose for anabolic processesJurgen R Haanstra, Arjen van Tuijl, Jan van Dam, et al.
ESMO Open|April 10, 2019
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastasesYanina J L Jansen, Gontran Verset, Kelly Schats, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2020
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastasesYanina Jansen, Vibeke Kruse, Jurgen Corthals, et al.
Pageof 5